In mammals, the microtubule-associated protein tau is located in the axons of neuronal cells and is believed to stabilize the microtubule cytoskeleton and function in neurite outgrowth. A C. elegans homologue of tau,
ptl-1 (protein with tau-like repeats), was identified by the C. elegans Genome Sequencing Consortium and characterized by us (McDermott et al, 1996, Biochemistry 35: 9415-9423) and Goedert et al. (1996, J. Cell Sci. 109:2661-2672). We obtained a C. elegans strain with a deletion of the repeat region from the NemaPharm Group at Axys Pharmaceuticals. The
ptl-1 deletion strain has no apparent phenotype and we have not detected differences between N2 and the
ptl-1 deletion strain in sensitivity to colchicine, benomyl or cytochalasin D. Work done by N. Hirokawa and colleagues has shown that in mice, tau functions redundantly with microtubule-associated protein MAP1B. Mice homozygous for a null allele of tau (Harada et al., 1994, Nature 369: 488-491) or MAP-1B (Takei et al., 1997, J. Cell Biol. 137: 1615-1626) have mild phenotypes, but double mutants have severe defects in brain development as a result of defects in neurite outgrowth (Takei et al., 1998, Mol. Biol. of the Cell 9:394a). Because of this precedent for redundancy in the function of tau and MAP-1B, we searched for C. elegans genome for a MAP1B homologue but no candidate was found. To attempt to identify proteins that act cooperatively or are redundant to
ptl-1 , we have begun a screen for synthetic mutations. We crossed the
ptl-1 deletion into a strain (obtained from David Baillie) that has cosmid F42G9 (containing
ptl-1 ) and
rol-6 as an extrachromosomal array. We will mutagenize the
ptl-1 deletion strain containing the F42G9 array to screen for genes that are synthetic to
ptl-1 .